[Insightec in BioSpace] SonALAsense announces completion of first cohort in phase 2 study of SONALA-001 sonodynamic therapy for recurrent glioblastoma

OAKLAND, Calif.–(BUSINESS WIRE)–Sonalasense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001 in combination with Insightec’s MR-guided focused ultrasound (MRgFUS), today announced that the first cohort in SDT-202 was fully enrolled.

Read more here.